Can a Two-Session 'Acceptance' therapy keep HIV patients in treatment?

NCT ID NCT04201288

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a short, two-session therapy called Acceptance-Based Behavior Therapy (ABBT) to help people newly diagnosed with HIV stay committed to their medical care. The therapy teaches coping skills to overcome barriers like fear of disclosure. Researchers tracked whether participants attended at least three medical visits in a year and achieved an undetectable viral load. The trial enrolled 38 adults and compared ABBT to standard HIV education.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Acceptance-Based Behavior Therapy (ABBT)
What this could lead to
If it works, this could offer a simple, short-term behavioral tool to help people newly diagnosed with HIV stay engaged in medical care and improve their health outcomes.
What could go wrong
This is a very small, early-stage study with only 38 participants, so results may not apply broadly. The intervention is behavioral, not a medical treatment, and its impact on long-term viral suppression is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease Medication Adherence Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brown University

    Providence, Rhode Island, 02912, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.